The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global market for Antacid was valued at US$ 6640 million in the year 2024 and is projected to reach a revised size of US$ 8308 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they"re also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.
In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antacid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antacid.
The Antacid market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antacid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antacid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter＆Gamble
GlaxoSmithKline
Johnson＆Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories
Segment by Type
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Segment by Application
OTC Drug
Rx Drug
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antacid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antacid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Antacid was valued at US$ 6640 million in the year 2024 and is projected to reach a revised size of US$ 8308 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they"re also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.
In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antacid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antacid.
The Antacid market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antacid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antacid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter＆Gamble
GlaxoSmithKline
Johnson＆Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories
Segment by Type
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Segment by Application
OTC Drug
Rx Drug
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antacid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antacid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antacid Market Overview
1.1 Product Definition
1.2 Antacid by Type
1.2.1 Global Antacid Market Value Comparison by Type (2024 VS 2031)
1.2.2 Proton Pump Inhibitor
1.2.3 H2 Antagonist
1.2.4 Acid Neutralizers
1.3 Antacid by Application
1.3.1 Global Antacid Market Value by Application (2024 VS 2031)
1.3.2 OTC Drug
1.3.3 Rx Drug
1.4 Global Antacid Market Size Estimates and Forecasts
1.4.1 Global Antacid Revenue 2020-2031
1.4.2 Global Antacid Sales 2020-2031
1.4.3 Global Antacid Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antacid Market Competition by Manufacturers
2.1 Global Antacid Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antacid Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antacid Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antacid, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antacid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antacid, Product Type & Application
2.7 Global Key Manufacturers of Antacid, Date of Enter into This Industry
2.8 Global Antacid Market Competitive Situation and Trends
2.8.1 Global Antacid Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antacid Players Market Share by Revenue
2.8.3 Global Antacid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antacid Market Scenario by Region
3.1 Global Antacid Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antacid Sales by Region: 2020-2031
3.2.1 Global Antacid Sales by Region: 2020-2025
3.2.2 Global Antacid Sales by Region: 2026-2031
3.3 Global Antacid Revenue by Region: 2020-2031
3.3.1 Global Antacid Revenue by Region: 2020-2025
3.3.2 Global Antacid Revenue by Region: 2026-2031
3.4 North America Antacid Market Facts & Figures by Country
3.4.1 North America Antacid Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antacid Sales by Country (2020-2031)
3.4.3 North America Antacid Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antacid Market Facts & Figures by Country
3.5.1 Europe Antacid Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antacid Sales by Country (2020-2031)
3.5.3 Europe Antacid Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antacid Market Facts & Figures by Region
3.6.1 Asia Pacific Antacid Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antacid Sales by Region (2020-2031)
3.6.3 Asia Pacific Antacid Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antacid Market Facts & Figures by Country
3.7.1 Latin America Antacid Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antacid Sales by Country (2020-2031)
3.7.3 Latin America Antacid Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antacid Market Facts & Figures by Country
3.8.1 Middle East and Africa Antacid Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antacid Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antacid Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antacid Sales by Type (2020-2031)
4.1.1 Global Antacid Sales by Type (2020-2025)
4.1.2 Global Antacid Sales by Type (2026-2031)
4.1.3 Global Antacid Sales Market Share by Type (2020-2031)
4.2 Global Antacid Revenue by Type (2020-2031)
4.2.1 Global Antacid Revenue by Type (2020-2025)
4.2.2 Global Antacid Revenue by Type (2026-2031)
4.2.3 Global Antacid Revenue Market Share by Type (2020-2031)
4.3 Global Antacid Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antacid Sales by Application (2020-2031)
5.1.1 Global Antacid Sales by Application (2020-2025)
5.1.2 Global Antacid Sales by Application (2026-2031)
5.1.3 Global Antacid Sales Market Share by Application (2020-2031)
5.2 Global Antacid Revenue by Application (2020-2031)
5.2.1 Global Antacid Revenue by Application (2020-2025)
5.2.2 Global Antacid Revenue by Application (2026-2031)
5.2.3 Global Antacid Revenue Market Share by Application (2020-2031)
5.3 Global Antacid Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Antacid Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Antacid Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Takeda Pharmaceutical
6.2.1 Takeda Pharmaceutical Company Information
6.2.2 Takeda Pharmaceutical Description and Business Overview
6.2.3 Takeda Pharmaceutical Antacid Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda Pharmaceutical Antacid Product Portfolio
6.2.5 Takeda Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Antacid Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Antacid Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Reckitt Benckiser
6.4.1 Reckitt Benckiser Company Information
6.4.2 Reckitt Benckiser Description and Business Overview
6.4.3 Reckitt Benckiser Antacid Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Reckitt Benckiser Antacid Product Portfolio
6.4.5 Reckitt Benckiser Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Antacid Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Antacid Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Procter＆Gamble
6.6.1 Procter＆Gamble Company Information
6.6.2 Procter＆Gamble Description and Business Overview
6.6.3 Procter＆Gamble Antacid Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Procter＆Gamble Antacid Product Portfolio
6.6.5 Procter＆Gamble Recent Developments/Updates
6.7 GlaxoSmithKline
6.7.1 GlaxoSmithKline Company Information
6.7.2 GlaxoSmithKline Description and Business Overview
6.7.3 GlaxoSmithKline Antacid Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GlaxoSmithKline Antacid Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Johnson＆Johnson
6.8.1 Johnson＆Johnson Company Information
6.8.2 Johnson＆Johnson Description and Business Overview
6.8.3 Johnson＆Johnson Antacid Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Johnson＆Johnson Antacid Product Portfolio
6.8.5 Johnson＆Johnson Recent Developments/Updates
6.9 CONBA
6.9.1 CONBA Company Information
6.9.2 CONBA Description and Business Overview
6.9.3 CONBA Antacid Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CONBA Antacid Product Portfolio
6.9.5 CONBA Recent Developments/Updates
6.10 Xiuzheng Pharma
6.10.1 Xiuzheng Pharma Company Information
6.10.2 Xiuzheng Pharma Description and Business Overview
6.10.3 Xiuzheng Pharma Antacid Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Xiuzheng Pharma Antacid Product Portfolio
6.10.5 Xiuzheng Pharma Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Company Information
6.11.2 Sanofi Description and Business Overview
6.11.3 Sanofi Antacid Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sanofi Antacid Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Bausch Health
6.12.1 Bausch Health Company Information
6.12.2 Bausch Health Description and Business Overview
6.12.3 Bausch Health Antacid Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Bausch Health Antacid Product Portfolio
6.12.5 Bausch Health Recent Developments/Updates
6.13 CR SANJIU
6.13.1 CR SANJIU Company Information
6.13.2 CR SANJIU Description and Business Overview
6.13.3 CR SANJIU Antacid Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CR SANJIU Antacid Product Portfolio
6.13.5 CR SANJIU Recent Developments/Updates
6.14 Reddy's Laboratories
6.14.1 Reddy's Laboratories Company Information
6.14.2 Reddy's Laboratories Description and Business Overview
6.14.3 Reddy's Laboratories Antacid Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Reddy's Laboratories Antacid Product Portfolio
6.14.5 Reddy's Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antacid Industry Chain Analysis
7.2 Antacid Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antacid Production Mode & Process Analysis
7.4 Antacid Sales and Marketing
7.4.1 Antacid Sales Channels
7.4.2 Antacid Distributors
7.5 Antacid Customer Analysis
8 Antacid Market Dynamics
8.1 Antacid Industry Trends
8.2 Antacid Market Drivers
8.3 Antacid Market Challenges
8.4 Antacid Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Antacid Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Antacid Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Antacid Market Competitive Situation by Manufacturers in 2024
Table 4. Global Antacid Sales (M Units) of Key Manufacturers (2020-2025)
Table 5. Global Antacid Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Antacid Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Antacid Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Antacid Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Antacid, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antacid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antacid, Product Type & Application
Table 12. Global Key Manufacturers of Antacid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antacid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antacid as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antacid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Antacid Sales by Region (2020-2025) & (M Units)
Table 18. Global Antacid Sales Market Share by Region (2020-2025)
Table 19. Global Antacid Sales by Region (2026-2031) & (M Units)
Table 20. Global Antacid Sales Market Share by Region (2026-2031)
Table 21. Global Antacid Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Antacid Revenue Market Share by Region (2020-2025)
Table 23. Global Antacid Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Antacid Revenue Market Share by Region (2026-2031)
Table 25. North America Antacid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Antacid Sales by Country (2020-2025) & (M Units)
Table 27. North America Antacid Sales by Country (2026-2031) & (M Units)
Table 28. North America Antacid Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Antacid Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Antacid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Antacid Sales by Country (2020-2025) & (M Units)
Table 32. Europe Antacid Sales by Country (2026-2031) & (M Units)
Table 33. Europe Antacid Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Antacid Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Antacid Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Antacid Sales by Region (2020-2025) & (M Units)
Table 37. Asia Pacific Antacid Sales by Region (2026-2031) & (M Units)
Table 38. Asia Pacific Antacid Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Antacid Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antacid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Antacid Sales by Country (2020-2025) & (M Units)
Table 42. Latin America Antacid Sales by Country (2026-2031) & (M Units)
Table 43. Latin America Antacid Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antacid Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Antacid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Antacid Sales by Country (2020-2025) & (M Units)
Table 47. Middle East and Africa Antacid Sales by Country (2026-2031) & (M Units)
Table 48. Middle East and Africa Antacid Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Antacid Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Antacid Sales (M Units) by Type (2020-2025)
Table 51. Global Antacid Sales (M Units) by Type (2026-2031)
Table 52. Global Antacid Sales Market Share by Type (2020-2025)
Table 53. Global Antacid Sales Market Share by Type (2026-2031)
Table 54. Global Antacid Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Antacid Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Antacid Revenue Market Share by Type (2020-2025)
Table 57. Global Antacid Revenue Market Share by Type (2026-2031)
Table 58. Global Antacid Price (USD/Unit) by Type (2020-2025)
Table 59. Global Antacid Price (USD/Unit) by Type (2026-2031)
Table 60. Global Antacid Sales (M Units) by Application (2020-2025)
Table 61. Global Antacid Sales (M Units) by Application (2026-2031)
Table 62. Global Antacid Sales Market Share by Application (2020-2025)
Table 63. Global Antacid Sales Market Share by Application (2026-2031)
Table 64. Global Antacid Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Antacid Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Antacid Revenue Market Share by Application (2020-2025)
Table 67. Global Antacid Revenue Market Share by Application (2026-2031)
Table 68. Global Antacid Price (USD/Unit) by Application (2020-2025)
Table 69. Global Antacid Price (USD/Unit) by Application (2026-2031)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. AstraZeneca Antacid Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Takeda Pharmaceutical Company Information
Table 76. Takeda Pharmaceutical Description and Business Overview
Table 77. Takeda Pharmaceutical Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Takeda Pharmaceutical Antacid Product
Table 79. Takeda Pharmaceutical Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Pfizer Antacid Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Reckitt Benckiser Company Information
Table 86. Reckitt Benckiser Description and Business Overview
Table 87. Reckitt Benckiser Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Reckitt Benckiser Antacid Product
Table 89. Reckitt Benckiser Recent Developments/Updates
Table 90. Bayer Company Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Bayer Antacid Product
Table 94. Bayer Recent Developments/Updates
Table 95. Procter＆Gamble Company Information
Table 96. Procter＆Gamble Description and Business Overview
Table 97. Procter＆Gamble Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Procter＆Gamble Antacid Product
Table 99. Procter＆Gamble Recent Developments/Updates
Table 100. GlaxoSmithKline Company Information
Table 101. GlaxoSmithKline Description and Business Overview
Table 102. GlaxoSmithKline Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. GlaxoSmithKline Antacid Product
Table 104. GlaxoSmithKline Recent Developments/Updates
Table 105. Johnson＆Johnson Company Information
Table 106. Johnson＆Johnson Description and Business Overview
Table 107. Johnson＆Johnson Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Johnson＆Johnson Antacid Product
Table 109. Johnson＆Johnson Recent Developments/Updates
Table 110. CONBA Company Information
Table 111. CONBA Description and Business Overview
Table 112. CONBA Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. CONBA Antacid Product
Table 114. CONBA Recent Developments/Updates
Table 115. Xiuzheng Pharma Company Information
Table 116. Xiuzheng Pharma Description and Business Overview
Table 117. Xiuzheng Pharma Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Xiuzheng Pharma Antacid Product
Table 119. Xiuzheng Pharma Recent Developments/Updates
Table 120. Sanofi Company Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Sanofi Antacid Product
Table 124. Sanofi Recent Developments/Updates
Table 125. Bausch Health Company Information
Table 126. Bausch Health Description and Business Overview
Table 127. Bausch Health Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Bausch Health Antacid Product
Table 129. Bausch Health Recent Developments/Updates
Table 130. CR SANJIU Company Information
Table 131. CR SANJIU Description and Business Overview
Table 132. CR SANJIU Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. CR SANJIU Antacid Product
Table 134. CR SANJIU Recent Developments/Updates
Table 135. Reddy's Laboratories Company Information
Table 136. Reddy's Laboratories Description and Business Overview
Table 137. Reddy's Laboratories Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Reddy's Laboratories Antacid Product
Table 139. Reddy's Laboratories Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Antacid Distributors List
Table 143. Antacid Customers List
Table 144. Antacid Market Trends
Table 145. Antacid Market Drivers
Table 146. Antacid Market Challenges
Table 147. Antacid Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antacid
Figure 2. Global Antacid Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antacid Market Share by Type: 2024 & 2031
Figure 4. Proton Pump Inhibitor Product Picture
Figure 5. H2 Antagonist Product Picture
Figure 6. Acid Neutralizers Product Picture
Figure 7. Global Antacid Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Antacid Market Share by Application: 2024 & 2031
Figure 9. OTC Drug
Figure 10. Rx Drug
Figure 11. Global Antacid Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Antacid Market Size (2020-2031) & (US$ Million)
Figure 13. Global Antacid Sales (2020-2031) & (M Units)
Figure 14. Global Antacid Average Price (USD/Unit) & (2020-2031)
Figure 15. Antacid Report Years Considered
Figure 16. Antacid Sales Share by Manufacturers in 2024
Figure 17. Global Antacid Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Antacid Players: Market Share by Revenue in Antacid in 2024
Figure 19. Antacid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Antacid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Antacid Sales Market Share by Country (2020-2031)
Figure 22. North America Antacid Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Antacid Sales Market Share by Country (2020-2031)
Figure 26. Europe Antacid Revenue Market Share by Country (2020-2031)
Figure 27. Germany Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Antacid Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Antacid Revenue Market Share by Region (2020-2031)
Figure 34. China Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Antacid Sales Market Share by Country (2020-2031)
Figure 45. Latin America Antacid Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Antacid Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Antacid Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Antacid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Antacid by Type (2020-2031)
Figure 55. Global Revenue Market Share of Antacid by Type (2020-2031)
Figure 56. Global Antacid Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Antacid by Application (2020-2031)
Figure 58. Global Revenue Market Share of Antacid by Application (2020-2031)
Figure 59. Global Antacid Price (USD/Unit) by Application (2020-2031)
Figure 60. Antacid Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
